Status:
UNKNOWN
Oral Nifedipine Versus IV Labetalol in Severe Pre Eclampsia
Lead Sponsor:
Services Institute of Medical Sciences, Pakistan
Conditions:
Severe Pre-Eclampsia, Antepartum
Eligibility:
FEMALE
18-40 years
Phase:
PHASE2
PHASE3
Brief Summary
OBJECTIVE: To determine the efficacy of nifedipine and labetalol in terms of control of BP in pre eclamptic pregnant patients Design: Randomised control trial SETTING: Department Obstetrics \& gynae...
Detailed Description
Gestational hypertension is associated with increased risk of maternal morbidity and mortality. Parenteral therapy needs more resources, more monitoring and supervision. Oral therapy is cheap, easily ...
Eligibility Criteria
Inclusion
- Gestational age 24 to 41 weeks
- BP \> 160/110 mm Hg with proteinuria
- Patients with S/S of imminent eclampsia as headache, visual disturbance.
Exclusion
- Gestational age \< 24 wks
- Non proteinuric chronic hypertension
- Eclampsia
- Cardiac patients, asthma, severe renal disease, allergy to Nifedipine or Labetalol
Key Trial Info
Start Date :
February 23 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 15 2018
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT03325348
Start Date
February 23 2017
End Date
January 15 2018
Last Update
October 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Services Institute of Medical Sciences
Lahore, Punjab Province, Pakistan